Skip to main content
OpenTrials
Completed

NCT Number: NCT02408614

Acute Effect of Exercise on Vascular Function

The study objectives are the following: 1) To examine the acute vascular responses to continuous low- and moderate-intensity exercise and interval training; and 2) To examine the influence of age and gender on these responses.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–79 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Integrative Cardiovascular Physiology Laboratory

Gainesville, Florida, 32611, United States

About this study

The type, intensity and duration of exercise, fitness state, and timing of measurements have been reported to influence the acute vascular responses to exercise. However, little is known regarding the influence of interval training, aging and gender on these responses. The objectives of this study are: 1) to examine the acute vascular responses to continuous low- and moderate-intensity exercise and interval training; and 2) to examine the influence of age and gender on these responses. Subjects will perform the following 3 types of treadmill exercise in a random order: 1) slow-pace walking; 2) moderate-pace walking; and 3) interval training. Flow mediated dilation using high resolution ultrasonography and arterial stiffness using applanation tonometry will be measured before, immediately after and 1-hour after each acute bout of exercise.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women 18 to 79 years of age
  • Women will be premenopausal or postmenopausal (either natural or surgical) defined as a cessation of menses for at least 2 years.
  • Premenopausal women will be eumenorrheic.
  • Able to give consent.

Exclusion criteria

  • History of hepatic disease or infection with hepatitis B, C or HIV
  • History of other relevant on-going or recurrent illness
  • Recent (within 3 months) or recurrent hospitalizations
  • Current intake of medications that may affect study results
  • Use of tobacco products
  • Premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy.
  • Pregnancy (positive urine pregnancy test) or lactation
  • Perimenopausal women

Treatment and study plan

Slow-paced walking

Other

Subjects will complete 47 minutes of walking on a treadmill at a slow-pace.

Moderate-paced walking

Other

Subjects will complete 47 minutes of walking on a treadmill at a moderate pace.

Interval training

Other

Subjects will complete 40 minutes of walking on the treadmill alternating between a moderate and a fast pace.

Treadmill

Device

Primary outcomes

  1. Change in vascular endothelial function

    Time frame: Baseline, 15 minutes after exercise and 1 hour after exercise

    Brachial artery endothelium-dependent flow-mediated dilation to reactive hyperemia will be measured using high resolution ultrasonography. Brachial artery diameter and blood velocity will be measured before and after occluding the forearm for 5 minutes by inflating a cuff to 250 mmHg.

Secondary outcomes

  1. Change in arterial stiffness

    Time frame: Baseline, 15 minutes after exercise and 1 hour after exercise

    Arterial stiffness (aortic pulse wave velocity and augmentation index) will be measured using applanation tonometry.

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Registry information

Important dates

Study start
2015
Primary completion
2019
Study completion
2019
First posted
Apr 3, 2015
Registry last updated
Jan 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.